Showing results (121-130 of 187) with videos related to

Sort By:
Pageof 19
Ejhaem|April 28, 2025
Enhanced Disease Detection of Hairy Cell Leukaemia Through Next-Generation Sequencing Based BRAF V600E and Phased Variant AnalysisSimon Wu, Tamia Nguyen, Imogen Caldwell, et al.
Journal of Visualized Experiments : Jove|August 20, 2019
Scalable Quantum Integrated Circuits on Superconducting Two-Dimensional Electron Gas PlatformKaveh Delfanazari, Pengcheng Ma, Reuben Puddy, et al.
Journal of Medical Microbiology|January 22, 2019
Utilizing genomic analyses to investigate the first outbreak of vanA vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibilityAbby P Douglas, Caroline Marshall, Sarah L Baines, et al.
The Journal of Infectious Diseases|April 22, 2017
Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell TransplantationMichelle K Yong, Paul U Cameron, Monica Slavin, et al.
Physical Review Letters|September 22, 2018
Imaging the Zigzag Wigner Crystal in Confinement-Tunable Quantum WiresSheng-Chin Ho, Heng-Jian Chang, Chia-Hua Chang, et al.
British Journal of Haematology|August 12, 2009
Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin LymphomaMichael Dickinson, David Ritchie, Daniel J DeAngelo, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 2026
Subtherapeutic posaconazole exposure during delayed-release tablet prophylaxis in high-risk patients with haematological malignancies: rationale for routine therapeutic drug monitoringKaren F Urbancic, Michelle K Yong, KarYee Yong, et al.
BMJ Open|February 12, 2020
Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE)Philip George, Nathaniel Dasyam, Giulia Giunti, et al.
Internal Medicine Journal|July 2, 2025
Design, implementation and evaluation of a model of care for patients with germline predisposition to haematological malignancy and bone marrow failure syndromesLucy C Fox, Erin Goode, Nicole Den Elzen, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 15, 2023
Evaluating the cost-effectiveness of [18F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patientsMichelle Tew, Abby P Douglas, Jeff Szer, et al.
Pageof 19